Trade names or approved names. Part III. Special cases. Clinical trials.
D001682:Biological Availability; D001702:Biopharmaceutics; D004341:Drug Evaluation / Q000592:standards*; D011307:Drug Prescriptions; D004918:Erythromycin Estolate / Q000009:adverse effects; D006801:Humans; D007213:Indomethacin / Q000097:blood; D012459:Salicylates / Q000097:blood; D013411:Sulfadiazine / Q000097:blood; D013810:Therapeutic Equivalency; D013997:Time Factors
D012459:Salicylates; D013411:Sulfadiazine; D004918:Erythromycin Estolate; D007213:Indomethacin